Here’s whether Roivant Sciences Ltd. Common Shares (ROIV) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.48% over 10 days); strong 1-year return of +207.4%; 3-month momentum positive (+21.2%). Currently 4.4% off its 52-week high. Score: +6/7.
ROIV is in a confirmed uptrend, trading above both its 50-day ($34.47) and 200-day ($27.75) moving averages. An RSI of 69.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +207.4% compares to +20.5% for SPY (beat the market by 186.9%).
$10,000 invested 1 year ago→ $30,737 today
vs. S&P 500 (SPY) — same period beat market by 186.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($27.75)
✓Above 50-day MA ($34.47)
✓RSI(14) neutral zone (30–70) — currently 69.8
✓Positive return (+207.4%)
✓Within 10% of period high (−4.4%)
Period Range $36.30
$11.54$37.97
RSI (14) 69.8
0 · OversoldOverbought · 100
Key Metrics
Price$36.30
Period Return+207.4%
Period High$37.97
Period Low$11.54
Drawdown−4.4%
MA-50$34.47
MA-200$27.75
RSI (14)69.8
Avg Volume (30d)5.2M
vs. SPYbeat by 186.9%
Return Rank#61 of 999
Trend Signals
Price is above the 200-day moving average ($27.75)